Cryptotanshinone was regarded as the STAT3 and STAT5 regulator for ischemic stroke (Zhu et al., 2021) and chronic myelocytic leukemia (Dong et al., 2018). This evidence concerns the gene STAT5B and chronic myelogenous leukemia, BCR-ABL1 positive.